scispace - formally typeset
F

Fernando Fuertes

Researcher at University of Zaragoza

Publications -  6
Citations -  2082

Fernando Fuertes is an academic researcher from University of Zaragoza. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 6, co-authored 6 publications receiving 2009 citations.

Papers
More filters
Journal ArticleDOI

Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes

Julius Gudmundsson, +79 more
- 01 Aug 2007 - 
TL;DR: Results from eight case-control groups demonstrate that this variant in TCF2 (HNF1β), a gene known to be mutated in individuals with maturity-onset diabetes of the young type 5, confers protection against type 2 diabetes.
Journal ArticleDOI

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

Julius Gudmundsson, +72 more
- 01 Mar 2008 - 
TL;DR: The 2p15 variant shows a significantly stronger association with more aggressive, rather than less aggressive, forms of the disease.
Journal ArticleDOI

Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility

TL;DR: In a multivariate analysis using 22 prostate cancer risk variants typed in the Icelandic population, it is estimated that carriers in the top 1.3% of the risk distribution are at a 2.5 times greater risk of developing the disease than members of the general population.
Journal ArticleDOI

A germline variant in the TP53 polyadenylation signal confers cancer susceptibility

Simon N. Stacey, +108 more
- 01 Nov 2011 - 
TL;DR: A genome-wide association study of 16 million SNPs identified through whole-genome sequencing of 457 Icelanders found that rs78378222 is in the 3′ untranslated region of TP53 and changes the AATAAA polyadenylation signal to AATACA, resulting in impaired 3′-end processing of TP 53 mRNA.
Journal ArticleDOI

A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer.

TL;DR: A new low-frequency variant at 8q24 associated with prostate cancer in European populations, rs188140481[A] is identified and its association remains significant after adjustment for all known risk-associated variants.